Ingredients
Dermisil H-Formula is medically proven to reduce herpes outbreaks safely and effectively. Dermisil H-Formula is 100% natural plant extracts that exclusively target the herpes virus safely and effectively. Ending herpes outbreaks becomes a possibility using these breakthrough anti-viral plant extracts.
After spending years of research on homeopathic treatments for herpes and genital herpes, we have developed an exclusive formula not found in any other product. Plant extracts are used in 75% of all traditional pharmaceuticals world-wide.
The active components of Dermisil H-Formula are high levels of neral, geraniol, alpha-terpinenes, and linalool. All are very effective anti-viral and anti-inflammatory components found in the plant extracts melissa offficinalis, melaleuca alternifolia, agathophyllum aromatica, avendula augustifolia, and additional key anti-viral plant extracts. All of these compounds have medically proven anti-viral properties and are highly effective in combating the HSV1 and HSV2 virus that cause herpes.
When using these extracts, achieving remission of your herpes outbreaks is possible.
These plant extracts have a low molecular weight and are lipophilic, which allows them to quickly absorbs into and underneath the herpes outbreak area as soon as they are applied. Other creams and medications sit on top of the skin, and do not penetrate as readily as plant extracts, therefore prolonging the healing process.
Our 100% Natural Dermisil H-Formula for Herpes Products
Our products work fastest and are most effective when used in combination with eachother. You can greatly speed your healing by using our triple-strike combination of:
- Dermisil H-Formula to eliminate an outbreak quickly
- Dermisil L-Lysine to aid in systemic healing of the herpes outbreak and speed healing, also to reduce frequency and severity of future outbreaks
- Dermisil H-Formula Daily to prevent future outbreaks
With our Triple-Strike combination, you can eliminate your current outbreak fast and be outbreak-free!
The product should not be used if you are pregnant or nursing.
Dermisil
H-Formula
10 ml
|
Dermisil
H-Formula
30ml
|
Dermisil
H-Formula Daily
10 ml
|
Dermisil
H-Formula Daily
30 ml
|
For quick elimination
of your Herpes
outbreak. Enough for
a mild outbreak.
|
For quick elimination
of your Herpes
outbreak. Enough for
a severe outbreak.
|
For daily use to prevent
and reduce the severity
of future outbreaks.
One-month supply for
mild outbreaks.
|
For daily use to prevent
and reduce the severity
of future outbreaks.
One-month supply for
severe outbreaks or
two-month supply for
milder outbreaks.
|
Value $34.95
SALE PRICE
$29.95
You save $10.00!
 |
Value $104.85
SALE PRICE
$62.95
You save $41.90!
|
Value $34.95
SALE PRICE
$29.95
You save $10.00!
|
Value $104.85
SALE PRICE
$62.95
You save $41.90!
|
|
|
*SPECIAL OFFER* |
|
Dermisil
L-Lysine - 100 Tablets, 500 mg each
For quick elimination of a herpes outbreak and long-term suppression of the herpes virus to prevent outbreaks. |
Dermisil
H-Formula Super Pack (10 ml each of H-Formula & H-Formula daily, and our Super L-Lysine, 1-month supply) |
Dermisil
H-Formula Super Pack MONTHLY SPECIAL **Details Below |
Dermisil
H-Formula Super Pack Plus (30 ml each of H-Formula & H-Formula daily, and 3 bottles Super L-Lysine, 3-month supply) |
Value $29.95
SALE PRICE
$19.95
You save $10.00!
|
Value $79.85
SALE PRICE
$59.95
You save $11.90!
|
Value $79.85
SALE PRICE
$59.95
You save $19.90!
|
Value $185.75
SALE PRICE
$139.95
You save $45.80!
|
Dermisil H-Formula Super Pack MONTHLY SPECIAL details: With your first order, you will receive one month's supply of Dermisil L-Lysine and Dermisil H-Formula Daily (10 ml), and we will include our Dermisil H-Formula (10 ml) absolutely FREE! Then, every month we will automatically send you your supply of Dermisil L-Lysine and Dermisil H-Formula Daily at the same low price of $34.95. That's just over $1 a day to keep outbreaks away!
We offer the total package to end your Herpes nightmare... and with our 60 DAY GUARANTEE, you can rest assured that we stand behind our products.
Medical Studies
Extract (Lo-701) for topical treatment of recurring herpes labialis.
Koytchev R, Alken RG, Dundarov S.
Cooperative Clinical Drug Research and Development GmbH, Berlin, Germany. ccdrd@drug-news.com
A double-blind, placebo-controlled, randomized trial was carried out with the aim of proving efficacy of standardized balm mint cream [active ingredient: 1% Lo-701--extract from Melissa officinalis (70:1)] for the therapy of herpes simplex labialis. Sixty six patients with a history of recurrent herpes labialis (at least four episodes per year) in one center were treated topically; 34 of them with verum and 32 with placebo. The cream had to be smeared on the affected area four times daily over five days. A combined symptom score of the values for complaints, size of affected area and blisters at day 2 of therapy was formed as the primary target parameter. There was a significant difference in the values of the primary target parameter between both treatment groups: verum 4.03 +/- 0.33 (3.0); placebo 4.94 +/- 0.40 (5.0); values given are mean +/- SEM (median) of the symptoms score on day 2 of therapy. The tested formulation is effective for the treatment of herpes simplex labialis. The significant difference in the combined symptom score on the second day of treatment is of particular importance having in mind that the complaints in patients suffering from herpes labialis are usually most intensive at that time. In addition to the shortening of the healing period, the prevention of a spreading of the infection and the rapid effect on typical symptoms of herpes like itching, tingling, burning, stabbing, swelling, tautness and erythema, the balm mint cream has a further advantage. The different mechanism of action of the extract rules out the development of resistance of the herpes virus. Some indication exists that the intervals between the periods with herpes might be prolonged with melissa. |
PMID: 10589440 [PubMed - indexed for MEDLINE]
Antiviral activity of Melissa officinalis and other plant extracts against Herpes simplex virus type-2.
Allahverdiyev A, Duran N, Ozguven M, Koltas S.
Tropical Diseases Center, Faculty of Medicine, Cukurova University, Adana, Turkey.
Melissa officinalis L. (Lamiaceae)and other plant extracts have been used in a variety of practical applications in medical science. Our objective in the current study was to determine the effects of the volatile oil components of M. officinalis on Herpes simplex virus type 2 (HSV-2) replication in HEp-2 cells. Four different concentrations (25, 50, 100, 150 and 200 microg/ml) of volatile oils were examined. Experiments were carried out using HEp-2 cells. M. officinalis volatile oil was found to be non-toxic to HEp-2 cells up to a concentration of 100 micro/ml. It was, however, found to be slightly toxic at a concentration over of 100 microg/ml. The antiviral activity of non-toxic concentrations against HSV-2 was tested. The replication of HSV-1, and HSV-2 was inhibited, indicating that the M. officinalis and other plant extracts contain anti-HSV-2 substances.
PMID: 15636181 [PubMed - indexed for MEDLINE]
Antiviral activity of Australian Melaleuca alternifolia and eucalyptol plant extracts against herpes simplex virus in cell culture.
Schnitzler P, Schon K, Reichling J.
Department of Virology, Hygiene Institute, University of Heidelberg, Germany.
The antiviral effect of Melaleuca alterfernolia (TTO) and eucalyptol (EUO) and other plant extracts against herpes simplex virus was examined. Cytotoxicity of TTO and EUO was evaluated in a standard neutral red dye uptake assay. Toxicity of TTO and EUO was moderate for RC-37 cells and approached 50% (TC50) at concentrations of 0.006% and 0.03%, respectively. Antiviral activity of TTO and EUO against herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) was tested in vitro on RC-37 cells using a plaque reduction assay. The 50% inhibitory concentration (IC50) of TTO for herpes simplex virus plaque formation was 0.0009% and 0.0008% and the IC50 of EUO was determined at 0.009% and 0.008% for HSV-1 and HSV-2, respectively. Australian tea tree oil exhibited high levels of virucidal activity against HSV-1 and HSV-2 in viral suspension tests. At noncytotoxic concentrations of TTO plaque formation was reduced by 98.2% and 93.0% for HSV-1 and HSV-2, respectively. Noncytotoxic concentrations of EUO reduced virus titers by 57.9% for HSV-1 and 75.4% for HSV-2. Virus titers were reduced significantly with TTO, whereas EUO exhibited distinct but less antiviral activity. In order to determine the mode of antiviral action of both essential oils, either cells were pretreated before viral infection or viruses were incubated with TTO or EUO before infection, during adsorption or after penetration into the host cells. Plaque formation was clearly reduced, when herpes simplex virus was pretreated with the essential oils prior to adsorption. These results indicate that TTO and EUO affect the virus before or during adsorption, but not after penetration into the host cell. Thus TTO and EUO are capable to exert a direct antiviral effect on HSV. Although the active antiherpes components of Australian tea tree and eucalyptus oil are not yet known, their possible application as antiviral agents in recurrent herpes infection is promising.
PMID: 11338678 [PubMed - indexed for MEDLINE]
Subjective Response to Lysine in the Therapy of Herpes Simplex.
Walsh DE, Griffith RS, Behforooz A.
To test the effect of lysine supplementation on herpes infection, 1543 subjects were surveyed by questionnaire after a six-month trial period. The study included subjects with cold sores, canker sores, and genital herpes. Of these, 54% had been diagnosed and treated by a physician. The results showed that the average dosage used was 936 mg of lysine daily. Eighty-four per cent of those surveyed said that lysine supplementation prevented recurrence or decreased the frequency of herpes infection. Whereas 79% described their symptoms as severe or intolerable without lysine, only 8% used these terms when taking lysine. Without lysine, 90% indicated that healing took six to 15 days, but with lysine 83% stated that lesions healed in five days or less. Overall, 88% considered supplemental lysine an effective form of treatment for herpes infection.
PMID: 6423612 [PubMed - indexed for MEDLINE] |
